☆ 4.3 Article

Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal

EXPERT OPINION ON DRUG SAFETY (2023)

Related references

Note: Only part of the references are listed.

Review Clinical Neurology

The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

Christian Lampl et al.

Summary: This article conducted a systematic review and network meta-analysis to compare the safety and efficacy of different drugs for migraine prophylaxis. The study found that CGRP receptor monoclonal antibodies, gepants, and topiramate have the best efficacy in reducing monthly migraine days. Additionally, there is evidence supporting the efficacy of beta-blockers, valproate, and amitriptyline.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Article Clinical Neurology

Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial

Uwe Reuter et al.

Summary: In this study comparing erenumab to topiramate for migraine prophylaxis, erenumab demonstrated a more favorable tolerability and efficacy profile, with fewer patients discontinuing medication due to adverse events and significantly more patients achieving a >= 50% reduction in monthly migraine days.

CEPHALALGIA (2022)

Add to Collection

Article Clinical Neurology

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

Richard B. Lipton et al.

Summary: The OVERCOME (US) 2018 study revealed slow but steady progress in the diagnosis and preventive treatment of migraines, but many patients still have unmet needs in terms of consulting, diagnosis, and treatment. Additionally, there are varying unmet needs within the category of episodic migraines.

HEADACHE (2022)

Add to Collection

Review Clinical Neurology

The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

Lars Jacob Stovner et al.

Summary: This article summarizes the epidemiological studies of headache disorders globally, finding that headache disorders remain highly prevalent worldwide, and identifies methodological factors explaining the large variation between study findings. While migraine prevalence estimates increased over time, estimates for all headache types varied between world regions.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Article Clinical Neurology

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

Marte-Helene Bjork et al.

Summary: This study found that prenatal exposure to antiseizure medication is associated with an increased risk of neurodevelopmental disorders in children, especially when exposed to topiramate, valproate, and certain duotherapies.

JAMA NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study

Holly M. Crowe et al.

Summary: This study evaluates the association between pre-pregnancy migraine diagnosis and medication use with the risk of spontaneous abortion. The findings suggest that the use of certain migraine medications may increase the risk of spontaneous abortion.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Article Clinical Neurology

Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study

Marc Ehrlich et al.

Summary: The HER-MES trial was the first head-to-head study comparing erenumab to topiramate, and the results demonstrated that erenumab had better tolerability and efficacy in treating migraines.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Review Clinical Neurology

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention-2022 update

Simona Sacco et al.

Summary: This guideline evaluated the effectiveness and safety of monoclonal antibodies targeting the CGRP pathway for migraine prevention through systematic review and literature analysis, and provided updated treatment recommendations.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Article Clinical Neurology

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

Jessica Ailani et al.

Summary: This update aims to incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults. It provides practical recommendations based on expanded evidence base and emerging expert consensus, in the absence of a formal guideline.

HEADACHE (2021)

Add to Collection

Review Clinical Neurology

Diagnosis and management of migraine in ten steps

Anna K. Eigenbrodt et al.

Summary: Migraine is a common but often under-diagnosed and under-treated condition. The Consensus Statement provides guidelines for diagnosis and management, emphasizing the importance of patient education and patient-centered care.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment

A. Ducros et al.

Summary: This article presents the updated French guidelines for the management of migraine, focusing on pharmacological treatment including acute attacks, prophylaxis, and special considerations for women. The guidelines provide recommendations for different situations encountered in clinical practice, offering guidance for healthcare providers and patients.

REVUE NEUROLOGIQUE (2021)

Add to Collection

Editorial Material Clinical Neurology

Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019

T. J. Steiner et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Add to Collection

Article Clinical Neurology

OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients

Ho-Tin Wong et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Add to Collection

Article Genetics & Heredity

Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability

Jill Clayton-Smith et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Add to Collection

Article Clinical Neurology

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

John F. Rothrock et al.

HEADACHE (2019)

Add to Collection

Article Clinical Neurology

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation

Efstratia Vatzaki et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Add to Collection

Article Clinical Neurology

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

Lars Bendtsen et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Add to Collection

Review Medicine, General & Internal

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes

Areti Angeliki Veroniki et al.

BMC MEDICINE (2017)

Add to Collection

Article Clinical Neurology

A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience

Andrea Negro et al.

JOURNAL OF HEADACHE AND PAIN (2016)

Add to Collection

Article Pharmacology & Pharmacy

Risks of Congenital Malformations in Offspring Exposed to Valproic Acid In Utero: A Systematic Review and Cumulative Meta-analysis

M. Tanoshima et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)

Add to Collection

Meeting Abstract Clinical Neurology

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program

S. Silberstein et al.

JOURNAL OF HEADACHE AND PAIN (2013)

Add to Collection

Meeting Abstract Clinical Neurology

OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT

D. Dodick et al.

JOURNAL OF HEADACHE AND PAIN (2013)

Add to Collection

Article Clinical Neurology

Italian guidelines for primary headaches: 2012 revised version

Paola Sarchielli et al.

JOURNAL OF HEADACHE AND PAIN (2012)

Add to Collection

Article Medicine, General & Internal

Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations.

Janneke Jentink et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

Review Reproductive Biology

Valproic acid in pregnancy: How much are we endangering the embryo and fetus?

Asher Ornoy

REPRODUCTIVE TOXICOLOGY (2009)

Add to Collection

Review Clinical Neurology

Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts

Kimford Meador et al.

EPILEPSY RESEARCH (2008)

Add to Collection

Article Clinical Neurology

Migraine prevalence, disease burden, and the need for preventive therapy

R. B. Lipton et al.

NEUROLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.